HOME Top Market Reports Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs) - Global Forecast 2022

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs) - Global Forecast 2022

By: marketsandmarkets.com
Publishing Date: November 2017
Report Code: BT 3380

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global genome editing market is projected to reach USD 6.28 Billion by 2022 from USD 3.19 Billion in 2017, at a CAGR of 14.5% during the forecast period. The key factors propelling the growth of this market are rising government funding and growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics. Base year considered for the report is 2016 and the forecast period is 2017–2022.

Objectives of the Study:

  • To define, describe, and forecast the global genome editing/engineering market on the basis of technology, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To forecast the size of market segments with respect to four regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To analyze the market structure, profile key players of the global genome editing/engineering market, and comprehensively analyze their core competencies
  • To track and analyze competitive developments such as partnerships, agreements, collaborations, expansions, acquisitions, and product & service launches in the market

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global genome editing/genome engineering market and estimate the size of other dependent submarkets. Various secondary sources such as associations like the U.S. Food and Drug Administration, International Mammalian Genome Society, Genome Canada, World Bank, National Human Genome Research Institute (NHGRI), Genetics Society of America (GSA), European Society of Human Genetics (ESHG), British Society of Human Genetics, directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

Genome Editing / Genome Engineering Market

To know about the assumptions considered for the study, download the pdf brochure

The prominent players in the global genome editing/genome engineering market are Thermo Fisher Scientific (US), Merck (Germany), and Horizon Discovery Group (UK).

Target Audience:

  • Suppliers and distributors of genome editing/genome engineering technologies
  • Research institutes
  • Vendors/service providers

Scope of the Report:

The research report categorizes the genome editing/genome engineering market into the following segments and subsegments:

By Technology       

  • CRISPR
  • TALEN
  • ZFN
  • Antisense
  • Other technologies (PiggyBac, Flp-In, Adenine Base Editor (ADE), and Jump-In)

By Application

  • Cell line Engineering
  • Genetic Engineering
  • Other Applications (Diagnostics and Therapeutics)

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations

By Region

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe (RoE)
  • APAC
    • China
    • Japan
    • India
    • RoAPAC
  • Rest of the World
    • LATAM
    • MEA

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Secondary Sources
           2.1.2 Primary Research
                    2.1.2.1 Breakdown of Primaries
                    2.1.2.2 Key Data From Primary Sources
    2.2 Market Size Estimation
    2.3 Market Data Validation and Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 28)

4 Premium Insights (Page No. - 32)
    4.1 Genome Editing: Market Overview
    4.2 Europe: Genome Editing Market, By Application
    4.3 Genome Editing Market, By End User
    4.4 Genome Editing Market, By Country/Region

5 Market Overview (Page No. - 35)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Government Funding and Growth in the Number of Genomics Projects
                    5.2.1.2 Growing Application Areas of Genomics
                    5.2.1.3 High Prevalence of Infectious Diseases and Cancer
                    5.2.1.4 Technological Advancements
                    5.2.1.5 Increasing Production of Genetically Modified Crops
           5.2.2 Restraints
                    5.2.2.1 Dearth of Trained Professionals
                    5.2.2.2 Adverse Public Perception of Genetic Research
           5.2.3 Opportunities
                    5.2.3.1 Use of Genome Editing in Specialized/Personalized Medicine
                    5.2.3.2 Emerging Markets
           5.2.4 Challenges
                    5.2.4.1 High Cost of Genomics Equipment
                    5.2.4.2 Off-Target Effect of Crispr
                    5.2.4.3 Secure Storage of Large Volumes of Sequenced Data

6 Genome Editing Market, By Technology (Page No. - 43)
    6.1 Introduction
    6.2 Crispr
    6.3 Talen
    6.4 ZFN
    6.5 Antisense
    6.6 Other Technologies

7 Genome Editing Market, By Application (Page No. - 51)
    7.1 Introduction
    7.2 Cell Line Engineering
    7.3 Genetic Engineering
           7.3.1 Animal Genetic Engineering
           7.3.2 Plant Genetic Engineering
    7.4 Other Applications

8 Genome Editing Market, By End User (Page No. - 60)
    8.1 Introduction
    8.2 Biotechnology & Pharmaceutical Companies
    8.3 Academic & Government Research Institutes
    8.4 Contract Research Organizations

9 Genome Editing Market, By Region (Page No. - 65)
    9.1 Introduction
    9.2 North America
           9.2.1 US
                    9.2.1.1 Research Grants and Funding By Government Institutes
                    9.2.1.2 Increasing Use of Gm Crops
                    9.2.1.3 Prevalence of Alzheimer’s Disease and Other Dementias in the US
                    9.2.1.4 Genome Editing Conferences in the US
                    9.2.1.5 Increasing Prevalence of Cancer
                    9.2.1.6 Strategic Developments in the US Market
           9.2.2 Canada
                    9.2.2.1 Availability of Research Funding in Canada
                    9.2.2.2 Rising Incidence of Cancer
                    9.2.2.3 Gapp to Intensify Genomic R&D
    9.3 Europe
           9.3.1 Germany
                    9.3.1.1 Presence of A Large Number of Academic Institutes
                    9.3.1.2 Availability of Funding for Life Science Research
                    9.3.1.3 Conferences/Meetings/Symposiums/Workshops in Germany
           9.3.2 UK
                    9.3.2.1 Increasing Funds and Grants By Government Bodies
                    9.3.2.2 100,000 Genomes Project in the UK
           9.3.3 France
                    9.3.3.1 Increasing Government Investments in Genomics
                    9.3.3.2 Introduction of Noninvasive Prenatal Testing in France
           9.3.4 RoE
                    9.3.4.1 Spain’s Focus on Research
                    9.3.4.2 Growth in the Italian Biotech and Pharma Sectors
                    9.3.4.3 Growing Research Investments in Sweden & Denmark
    9.4 Asia Pacific
           9.4.1 China
                    9.4.1.1 Government Initiatives to Support Healthcare Research in China
                    9.4.1.2 Efforts of BGI to Boost the Genomics Market in China
                    9.4.1.3 High Intensity of R&D Activities in China
           9.4.2 Japan
                    9.4.2.1 Increasing Government Focus on Cancer Research
                    9.4.2.2 Conferences and Symposiums on Genetic Engineering in Japan
                    9.4.2.3 Focus on Cancer Research and Treatment
           9.4.3 India
                    9.4.3.1 Emergence of Local Players in India Backed By Government Funding
                    9.4.3.2 Increasing Support for Biotech Start-UPS
                    9.4.3.3 Growth of the Pharmaceutical Industry in India
           9.4.4 RoAPAC
                    9.4.4.1 Alliances and Partnerships in the Australian Market
                    9.4.4.2 Genome Asia 100k Initiative
                    9.4.4.3 Crop Research Initiatives in Asia
    9.5 RoW
           9.5.1 Latin America
                    9.5.1.1 Alliances, Availability of Government Funding in Brazil
                    9.5.1.2 Conferences & Workshops in Brazil (2016-2017)
           9.5.2 Middle East and Africa
                    9.5.2.1 Genetic Testing and Genomic Analysis in the Middle East
                    9.5.2.2 Rising Prevalence of HIV and Cancer in Africa

10 Competitive Landscape (Page No. - 117)
     10.1 Key Developments By Leading Players in the Genome Editing Market (2014-2017)
     10.2 Market Share Analysis
             10.2.1 Thermo Fisher Scientific
             10.2.2 Merck
             10.2.3 Horizon Discovery Group
     10.3 Competitive Scenario
             10.3.1 Agreements, Collaborations, and Partnerships
             10.3.2 Product & Service Launches, By Company
             10.3.3 Acquisitions
             10.3.4 Expansions

11 Company Profiles (Page No. - 125)
(Business Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments.)*
     11.1 Thermo Fisher Scientific
     11.2 Merck
     11.3 Horizon Discovery Group
     11.4 Genscript
     11.5 Sangamo Biosciences
     11.6 Integrated Dna Technologies
     11.7 Lonza
     11.8 New England Biolabs
     11.9 Origene Technologies
     11.10 Transposagen Biopharmaceuticals
     11.11 Editas Medicine
     11.12 Crispr Therapeutics

*Details on Business Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key Relationships Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 156)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Introducing RT: Real-Time Market Intelligence
     12.4 Available Customizations
     12.5 Related Reports
     12.6 Author Details


List of Tables (96 Tables)

Table 1 Global Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 2 Crispr-Based Genome Editing Market, By Country/Region, 2015–2022 (USD Million)
Table 3 Talen-Based Genome Editing Market, By Country/Region, 2015–2022 (USD Million)
Table 4 ZFN-Based Genome Editing Market, By Country/Region, 2015–2022 (USD Million)
Table 5 Antisense-Based Genome Editing Market, By Country/Region, 2015–2022 (USD Million)
Table 6 Genome Editing Market for Other Technologies, By Country/Region, 2015–2022 (USD Million)
Table 7 Global Genome Editing Market, By Application, 2015–2022 (USD Million)
Table 8 Genome Editing Market for Cell Line Engineering, By Country, 2015–2022 (USD Million)
Table 9 Genome Editing Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 10 Genome Editing Market for Genetic Engineering, By Country, 2015–2022 (USD Million)
Table 11 Genome Editing Market for Animal Genetic Engineering, By Country, 2015–2022 (USD Million)
Table 12 Genome Editing Market for Plant Genetic Engineering, By Country, 2015–2022 (USD Million)
Table 13 Genome Editing Market for Other Applications, By Country, 2015–2022 (USD Million)
Table 14 Global Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 15 Genome Editing Market for Biotechnology & Pharmaceutical Companies, By Region, 2015–2022 (USD Million)
Table 16 Genome Editing Market for Academic & Government Research Institutes, By Region, 2015–2022 (USD Million)
Table 17 Genome Editing Market for Contract Research Organizations, By Region, 2015–2022 (USD Million)
Table 18 Genome Editing Market, By Region, 2015–2022 (USD Million)
Table 19 Genome Editing Market, By Country/Region, 2015–2022 (USD Million)
Table 20 North America: Genome Editing Market, By Country, 2015–2022 (USD Million)
Table 21 North America: Genome Engineering Market, By Technology, 2015–2022 (USD Million)
Table 22 North America: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 23 North America: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 24 North America: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 25 US: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 26 US: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 27 US: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 28 US: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 29 Indicative List of Projects Funded By Gapp in 2014
Table 30 Canada: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 31 Canada: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 32 Canada: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 33 Canada: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 34 Conference, Meeting, Course and Workshop in Europe (2014-2018)
Table 35 Europe: Genome Editing Market, By Country, 2015–2022 (USD Million)
Table 36 Europe: Genome Engineering Market, By Technology, 2015–2022 (USD Million)
Table 37 Europe: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 38 Europe: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 39 Europe: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 40 Conferences, Meetings, Symposiums, Workshops in Germany (2014-2018)
Table 41 Germany: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 42 Germany: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 43 Germany: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 44 Germany: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 45 UK: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 46 UK: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 47 UK: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 48 UK: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 49 France: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 50 France: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 51 France: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 52 France: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 53 RoE: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 54 RoE: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 55 RoE: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 56 France: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 57 Asia Pacific: Genome Editing Market, By Country, 2015–2022 (USD Million)
Table 58 Asia Pacific: Genome Engineering Market, By Technology, 2015–2022 (USD Million)
Table 59 Asia Pacific: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 60 Asia Pacific: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 61 Asia Pacific: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 62 China: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 63 China: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 64 China: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 65 China: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 66 Conferences, Symposia, & Workshops in Japan, 2016-2018
Table 67 Japan: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 68 Japan: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 69 Japan: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 70 Japan: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 71 India: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 72 India: Genome Editing Market, By Application, 2015–2022 (USD Million)
Table 73 India: Genome Editing Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 74 Europe: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 75 RoAPAC: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 76 RoAPAC: Genome Editing Market, By Application, 2015–2022 (USD Million)
Table 77 RoAPAC: Genome Editing Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 78 RoAPAC: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 79 RoW: Genome Editing Market, By Region, 2015–2022 (USD Million)
Table 80 RoW: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 81 RoW: Genome Editing Market, By Application, 2015–2022 (USD Million)
Table 82 RoW: Genome Editing Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 83 RoW: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 84 Latam: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 85 Latam: Genome Editing Market, By Application, 2015–2022 (USD Million)
Table 86 Latam: Genome Editing Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 87 Latam: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 88 HIV Infections and Aids-Related Deaths in the Middle East and Africa, 2014
Table 89 MEA: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 90 MEA: Genome Editing Market, By Application, 2015–2022 (USD Million)
Table 91 MEA: Genome Editing Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 92 MEA: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 93 Agreements, Collaborations, and Partnerships, By Company (2015–2017)
Table 94 Product & Service Launches, By Company (2015–2017)
Table 95 Acquisitions, By Company (2015–2017)
Table 96 Expansions, By Company (2015–2017)


List of Figures (42 Figures)

Figure 1 Global Genome Editing Market Segmentation
Figure 2 Global Genome Editing Market: Research Methodology Steps
Figure 3 Research Design
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Bottom-Up Approach
Figure 6 Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Global Genome Editing Market, By Technology (2017–2022)
Figure 9 Global Genome Editing Market, By Application, 2017 vs 2022 (USD Million)
Figure 10 Global Genome Editing Market, By End User, 2017 vs 2022 (USD Million)
Figure 11 Geographical Snapshot of the Genome Editing Market
Figure 12 Rising Government Funding and High Prevalence of Infectious Diseases & Cancer—Key Growth Drivers of the Genome Editing Market
Figure 13 Cell Line Engineering Segment to Account for the Largest Market Share in 2017
Figure 14 Biotechnology & Pharmaceutical Companies Will Continue to Dominate the Genome Editing Market in 2022
Figure 15 North America to Register the Highest CAGR in the Forecast Period
Figure 16 Genome Editing Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Global Genome Editing Market, By Technology, 2017 vs 2022 (USD Million)
Figure 18 Global Genome Editing Market, By Application, 2017 vs 2022 (USD Million)
Figure 19 Genome Editing Market for Genetic Engineering, By Type, 2017 vs 2022 (USD Million)
Figure 20 Genome Editing Market, By End User, 2017 vs 2022 (USD Million)
Figure 21 Genome Editing Market, By Region, 2017 vs 2022 (USD Million)
Figure 22 North America: Genome Editing Market Snapshot
Figure 23 North Amarica: Number of New Cancer Cases, By Country
Figure 24 Prevalence of Alzheimer's Disease in the US, By Age (2016)
Figure 25 Europe: Genome Editing Market Snapshot
Figure 26 Europe: Number of New Cancer Cases, By Country
Figure 27 Asia Pacific: Genome Editing Market Snapshot
Figure 28 APAC: Number of New Cancer Cases, By Type
Figure 29 RoW: Genome Editing Market Snapshot
Figure 30 Market Share Analysis, By Key Player, 2016
Figure 31 Agreements, Collaborations, and Partnerships—Key Growth Strategy Adopted By Market Players
Figure 32 Agreements, Collaborations, and Partnerships, By Company (2014–2017)
Figure 33 Product & Service Launches, By Company (2014-2017)
Figure 34 Acquisitions, By Company (2014–2017)
Figure 35 Expansions, By Company (2014–2017)
Figure 36 Thermo Fisher Scientific: Company Snapshot
Figure 37 Merck: Company Snapshot
Figure 38 Horizon Discovery: Company Snapshot
Figure 39 Genscript : Company Snapshot
Figure 40 Sangamo Biosciences: Company Snapshot
Figure 41 Lonza: Company Snapshot
Figure 42 Editas Medicine: Company Snapshot

The global genome editing/genome engineering market is projected to reach USD 6.28 Billion by 2022 from USD 3.19 Billion in 2017, at a CAGR of 14.5%. The key factors propelling the growth of this market are rising government funding and growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics.

By technology, the genome editing/genome engineering market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies (PiggyBac, Flp-In, Adenine Base Editor (ADE), and Jump-In). The CRISPR segment is expected to account for the largest share of the market in 2017. Owing to the factors such as the ease of use associated with the CRISPR technology and the ability of CRISPR to multiplex.

On the basis of application, the genome editing/genome engineering market is segmented into cell line engineering, genetic engineering, and other applications (diagnostics and therapeutics). The cell line engineering segment is expected to account for the largest share of the market in 2017. Factors such as growing industry focus on stem cell research, increasing funding from governments and private organizations, and increasing global awareness about stem cell therapies are driving the growth of the segment.

On the basis of end user, the global genome editing/genome engineering market is segmented into pharmaceutical and biotechnology companies, academic & government research institutes, and contract research organizations. The pharmaceutical and biotechnology companies segment is estimated to account for the largest share of the global market in 2017. The increasing prevalence of infectious diseases and cancer are driving research activities worldwide; this is expected to drive the demand for genome editing in biotechnology & pharmaceutical companies.

Genome Editing / Genome Engineering Market

In 2017, North America is expected to account for the largest share of the genome editing/genome engineering market, followed by Europe. Factors such as the development of gene therapy in the US, increasing use of genetically modified crops, rising prevalence of infectious diseases and cancer, and rising availability of research grants and funding are propelling market growth in North America.

Factors such as dearth of skilled professionals and adverse public perception of genetic research are expected to limit the growth of the market to a certain extent.

The prominent players include Thermo Fisher Scientific (US), Merck (Germany), Horizon Discovery Group (UK), GenScript (US), Sangamo BioSciences (US), Integrated DNA Technologies (US), Lonza Group (Switzerland), New England Biolabs (US), OriGene Technologies (US), Transposagen Biopharmaceuticals (US), Editas Medicine (US), and CRISPR Therapeutics (Switzerland).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo